CompaniesZenopharm

Zenopharm

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (5)
View all

Total Trials

5

As Lead Sponsor

0

As Collaborator

5

Total Enrollment

4,098

By Phase

NA: 2PHASE1/PHASE2: 1PHASE3: 1PHASE4: 1

By Status

UNKNOWN: 2COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Today
NCT02547571
NCT02976805
NCT04669587
NCT05278897
Hover over trial bars to see details

Recent Trials

NCT06051955Collaborator
Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing
NARecruiting
120 participants
Started: Oct 11, 2023 · Completed: Sep 30, 2024
NCT05278897Collaborator
Hyaluronic Acid for Soft Tissue Injuries
NAUnknown
200 participants
Started: Mar 14, 2022 · Completed: May 13, 2024
NCT04669587Collaborator
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)
PHASE1/PHASE2Unknown
106 participants
Started: Jul 26, 2021 · Completed: Jan 31, 2024
NCT02976805Collaborator
Multi-centre Failed Bowel Prep RCT
PHASE3Completed
196 participants
Started: Feb 13, 2017 · Completed: Feb 19, 2020
NCT02547571Collaborator
The Bowel CLEAnsing: A National Initiative
PHASE4Completed
3,476 participants
Started: Mar 31, 2016 · Completed: Sep 30, 2018